For the future of health care, look no further than your wrist.
“Mobile display is the future of what we do,” Kevin Sayer told Bloomberg Law. He’s the chief executive officer of Dexcom, a medical device company with an FDA-approved blood glucose monitoring app featured on an Apple smart-watch.
It’s “an exciting time” for the medical device industry, Zach Rothstein, associate vice president of technology and regulatory affairs at AdvaMed, told Bloomberg Law. “We’re seeing a continued increase in companies moving toward app-based and digital health based products and tools in the FDA space.” AdvaMed represents roughly 300 companies that ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.